Understanding menstrual cycle development in girls after their first period
Official title: Reproductive Axis Maturation in the Early Post-Menarchal Years: A Pilot Study
Run by National Institutes of Health Clinical Center (CC) · NCT03986021 · Data updated 2026-11-12
This study looks at how girls aged 8-14 experience changes in their menstrual cycles in the two years after their first period to help understand normal puberty and identify early signs of hormonal problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 65 Years |
| Sex | Women only |
| Enrollment | 400 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Research Triangle Park, North Carolina) |
| Status | Recruiting |
| Started | December 19, 2019 |
| Main results expected | July 1, 2029 |
| Study ends | July 1, 2029 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT03986021 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy girls aged 8-14 who are either showing signs of puberty or have recently started their menstrual cycles.
✕Probably not a fit
Patients who are outside the age range or have chronic medical conditions affecting reproductive hormones may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate how girls' menstrual cycles evolve in the two years following their first period. It focuses on healthy girls aged 8-14 who are either pre-menarche or have recently started menstruating, as well as those at risk for polycystic ovarian syndrome (PCOS). The study will monitor physiological changes and menstrual regularity to better understand normal puberty and identify early signs of hormonal issues. By comparing these girls with women aged 18-34 with and without PCOS, researchers hope to uncover critical insights into reproductive health.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection and intervention for hormonal issues in adolescent girls, potentially improving long-term reproductive health.
How similar studies have gone: While studies on menstrual cycle irregularities exist, this specific focus on early post-menarcheal development and its implications for future health is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Part 1 - Pre-menarche monitoring ("holding pattern"):
Inclusion Criteria:
* Age 8-14.5 years old
* Healthy weight, defined as having a body weight \>85% of expected (EBW) and a body mass index (BMI) \<99th percentile
* Some breast development
* Pre-menarche
Exclusion Criteria:
* Taking or planning to take medications that affect reproductive hormones in the next 2 to 3 years (e.g. birth control pills, biotin supplements).
* Planning to move more than 60 miles from the CRU within the next 2 to 3 years
* Chronic medical condition, including but not limited to diabetes mellitus, congenital adrenal hyperplasia, cystic fibrosis, sickle cell disease, inflammatory bowel disease, juvenile rheumatoid arthritis, and lupus.
* First-degree relative with polycystic ovarian syndrome, premature ovarian insufficiency, hypogonadotropic hypogonadism, or other pubertal development disorder
* Excessive exercise (defined as running \>20 miles per week or its equivalent)
* Pregnancy
Part 2 - Post-menarche cycle tracking:
Inclusion Criteria:
* Age at menarche 10-14.5 years old
* Healthy weight, defined as having a body weight \>85% of expected (EBW) and a body mass index (BMI) \<99th percentile
* Approximately \< 6 months post-menarchal (will typically have completed 4 or fewer menstrual cycles)
* Biochemical criteria: normal thyroid hormone, prolactin, and testosterone levels
Exclusion Criteria:
* Taking or planning to take medications that affect reproductive hormones in the next 2 to 3 years (e.g. birth control pills, biotin supplements).
* Planning to move more than 60 miles from the CRU within the next 2 to 3 years
* Chronic medical condition, including but not limited to diabetes mellitus, congenital adrenal hyperplasia, cystic fibrosis, sickle cell disease, inflammatory bowel disease, juvenile rheumatoid arthritis, and lupus.
* First-degree relative with polycystic ovarian syndrome, premature ovarian insufficiency, hypogonadotropic hypogonadism, or other pubertal development disorder
* Excessive exercise (defined as running \>20 miles per week or its equivalent)
* Anemia (defined as hemoglobin \<12.0 g/dl)
--Participants with hemoglobin between 11.5 g/dl and 12.0 g/dl may still participate by providing dried blood spots, or no more than 18 ml of blood during any given interval.
* Pregnancy
Part 3 - Intensive monitoring of ovarian follicle growth
Inclusion Criteria:
* Age at menarche 10-14.5 years old
* Healthy weight, defined as having a body weight \>85% of expected (EBW) and a body mass index (BMI) \<99th percentile
* Within 1 year of menarche
* Biochemical criteria: normal thyroid hormone, prolactin, and testosterone levels
Exclusion Criteria:
* Taking or planning to take medications that affect reproductive hormones in the next 1-2 years (e.g. birth control pills, biotin supplements).
* Planning to move more than 60 miles from the CRU within the next year
* Chronic medical condition, including but not limited to diabetes mellitus, congenital adrenal hyperplasia, cystic fibrosis, sickle cell disease, inflammatory bowel disease, juvenile rheumatoid arthritis, and lupus.
* First-degree relative with polycystic ovarian syndrome, premature ovarian insufficiency, hypogonadotropic hypogonadism, or other pubertal development disorder
* Excessive exercise (defined as running \>20 miles per week or its equivalent)
* Anemia (defined as hemoglobin \<12.0 g/dl)
--Participants with hemoglobin between 11.5 g/dl and 12.0 g/dl may still participate by providing dried blood spots, or no more than 18 ml of blood during any given interval.
* Pregnancy
Part 4 - Late Post-menarche cycle tracking:
Inclusion Criteria:
* Age 11-17.5 years old
* Approximately 2-5 years post-menarchal
* Biochemical criteria: normal thyroid hormone and prolactin
Exclusion Criteria:
* Taking or planning to take medications that affect reproductive hormones in the next 2 to 3 years (e.g. birth control pills, biotin supplements).
* Planning to move more than 60 miles from the CRU within the next 6 months
* Chronic medical condition, including but not limited to diabetes mellitus, congenital adrenal hyperplasia, cystic fibrosis, sickle cell disease, inflammatory bowel disease, juvenile rheumatoid arthritis, and lupus.
* Anemia (defined as hemoglobin \<12.0 g/dl)
--Participants with hemoglobin between 11.5 g/dl and 12.0 g/dl may still participate by providing dried blood spots, or no more than 18 ml of blood during any given interval.
* Pregnancy
Adolescent girls, at-risk daughters, or sisters of women with PCOS
The girls with mothers or sisters with PCOS group will complete the Screening Visit and Parts 1-3. The same inclusion and exclusion criteria apply for Parts 1, 2, and 3 as stated above except that these individuals must have a first-degree relative with PCOS and they can have high androgen levels, excess body hair, and severe acne at screening.
Women with known PCOS (activities for 8 weeks only)
Inclusion Criteria:
* Age \>=18-34 years old
* PCOS diagnosis
* at least 3-years post-menarchal with irregular menstrual cycles
* Biochemical (blood) or clinical signs of high androgen levels
Exclusion Criteria:
* Cannot be taking any medications that affect reproductive or metabolic hormones (e.g. birth control pill, biotin supplements, spironolactone, metformin).
* Chronic medical condition, including but not limited to diabetes mellitus, congenital adrenal hyperplasia, cystic fibrosis, sickle cell disease, inflammatory bowel disease, juvenile rheumatoid arthritis, and lupus.
* Pregnancy
Healthy control women (Activities for 2 menstrual cycles)
Inclusion Criteria:
* Age \>=18-34 years old
* at least 3-years post-menarchal with regular menstrual cycles every 21-35 days
Exclusion Criteria:
* Cannot be taking any medications that affect reproductive or metabolic hormones (e.g. birth control pill, biotin supplements, spironolactone, metformin).
* Chronic medical condition, including but not limited to diabetes mellitus, congenital adrenal hyperplasia, cystic fibrosis, sickle cell disease, inflammatory bowel disease, juvenile rheumatoid arthritis, and lupus.
* PCOS diagnosis or first-degree relative with disorder
* Pregnancy
Mothers of pediatric participants (Activities for 8 weeks / 2 menstrual cycles)
Inclusion Criteria:
* Age \>=18-65 years old
* Biological mother of A Girl's First Period participant
Exclusion Criteria:
* Chronic medical condition, including but not limited to diabetes mellitus, congenital adrenal hyperplasia, cystic fibrosis, sickle cell disease, inflammatory bowel disease, juvenile rheumatoid arthritis, and lupus.
* Pregnancy
Where it's running
-
NIEHS Clinical Research Unit (CRU)
Research Triangle Park, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Natalie D Shaw, M.D. — National Institute of Environmental Health Sciences (NIEHS)
- Study coordinator: NIEHS Join A Study Recruitment Group
- Email: myniehs@nih.gov
- Phone: (855) 696-4347
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
GENESIS: Understanding mental health and lifestyle needs of Ecuadorian adolescents
This project will look at mental health and lifestyle habits in 14–19-year-olds in Quito to see if lifestyle factors relate to well‑being and risk for mental health problems.
-
EmoTIChealth: a serious game to strengthen emotional skills in teens with and without chronic conditions
This project will try a digital serious game for 12–16-year-olds to boost socioemotional skills and offer tailored support for teens with asthma, food allergy, type 1 diabetes, or allergic rhinitis.
-
Stress patterns and anhedonia during adolescence
We will see if combining brain scans, stress hormones, and heart-rate measures can identify patterns linked to developing anhedonia in 13–15-year-olds.
-
Understanding how anxiety affects substance use in adolescents
This study is trying to see how anxiety affects substance use in kids aged 12-14 by looking at their brain activity and stress responses.
-
Youth-led mental wellness program for secondary school students
This program will try to improve mental well-being, reduce depression and suicidal thoughts, and increase mental health knowledge and help-seeking among Hong Kong secondary school students in Forms 1–3.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.